Citation

90 FR 42251

Multiple canonical documents share this first-page citation.

Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Electronic Submissions of Medical Device Registration and Listing Friday, August 29, 2025 90 FR 42251
Amylyx Pharmaceuticals, Inc.; Withdrawal of Approval of New Drug Application for RELYVRIO (Sodium Phenylbutyrate and Taurursodiol) for Suspension, 3 Gram/Packet and 1 Gram/Packet Friday, August 29, 2025 90 FR 42251